These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34796668)

  • 1. Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia.
    D'Arena G; Volpe S; Amodeo R; Tirino V; D'Auria F; Annamaria G; Pietrantuono G; Laurenti L; Aiello A; Musto P
    Int J Lab Hematol; 2022 Jun; 44(3):e120-e122. PubMed ID: 34796668
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations.
    Wierda WG; Rawstron A; Cymbalista F; Badoux X; Rossi D; Brown JR; Egle A; Abello V; Cervera Ceballos E; Herishanu Y; Mulligan SP; Niemann CU; Diong CP; Soysal T; Suzuki R; Tran HTT; Wu SJ; Owen C; Stilgenbauer S; Ghia P; Hillmen P
    Leukemia; 2021 Nov; 35(11):3059-3072. PubMed ID: 34168283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia.
    Moreno C; Villamor N; Colomer D; Esteve J; Giné E; Muntañola A; Campo E; Bosch F; Montserrat E
    Blood; 2006 Jun; 107(11):4563-9. PubMed ID: 16449533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies.
    Böttcher S
    Methods Mol Biol; 2019; 1956():157-197. PubMed ID: 30779035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRD in CLL.
    Hillmen P
    Clin Adv Hematol Oncol; 2006 May; 4(5):6-7; discussion 10; suppl 12. PubMed ID: 16830420
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.
    Kay NE
    Clin Adv Hematol Oncol; 2008 Oct; 6(10):727-9. PubMed ID: 18997661
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of Minimal Residual Disease in Chronic Lymphocytic Leukemia].
    Doubek M
    Klin Onkol; 2015; 28 Suppl 3():3S16-21. PubMed ID: 26489497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing minimal residual disease in chronic lymphocytic leukemia.
    Rawstron AC; Hillmen P
    Curr Hematol Malig Rep; 2008 Jan; 3(1):47-53. PubMed ID: 20425446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR.
    Raponi S; Della Starza I; De Propris MS; Del Giudice I; Mauro FR; Marinelli M; Di Maio V; Piciocchi A; Foà R; Guarini A
    Br J Haematol; 2014 Aug; 166(3):360-8. PubMed ID: 24735016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and impact of minimal residual disease on outcome of chronic lymphocytic leukemia].
    Plander M; Skrapits J; Bozsó T; Szendrei T; Iványi JL
    Orv Hetil; 2012 Oct; 153(41):1622-8. PubMed ID: 23045312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?
    Dreger P; Ritgen M; Böttcher S; Schmitz N; Kneba M
    Leukemia; 2005 Jul; 19(7):1135-8. PubMed ID: 16074500
    [No Abstract]   [Full Text] [Related]  

  • 12. Performance of eight-color dry antibody reagent in the detection of minimal residual disease in chronic lymphocytic leukemia samples.
    Bento L; Correia R; de Sousa F; Vaz A; Pedro E; Schimidell D; Millan N; Passaro M; Barroso R; Bacal N
    Cytometry B Clin Cytom; 2020 Nov; 98(6):529-535. PubMed ID: 32251553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches.
    Tomuleasa C; Selicean C; Cismas S; Jurj A; Marian M; Dima D; Pasca S; Petrushev B; Moisoiu V; Micu WT; Vischer A; Arifeen K; Selicean S; Zdrenghea M; Bumbea H; Tanase A; Grewal R; Pop L; Aanei C; Berindan-Neagoe I
    Crit Rev Clin Lab Sci; 2018 Aug; 55(5):329-345. PubMed ID: 29801428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease assessment in chronic lymphocytic leukaemia.
    Sayala HA; Rawstron AC; Hillmen P
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):499-512. PubMed ID: 17707836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection and significance of minimal residual disease in acute and chronic leukemia.
    Chung NG; Buxhofer-Ausch V; Radich JP
    Tissue Antigens; 2006 Nov; 68(5):371-85. PubMed ID: 17092250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of minimal residual disease in chronic lymphocytic leukemia.
    Schweighofer CD; Hallek M; Wendtner CM
    Curr Hematol Malig Rep; 2008 Jan; 3(1):54-60. PubMed ID: 20425447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease in B-cell chronic lymphocytic leukaemia by flow cytometry.
    García Vela JA; Delgado I; García Alonso L; Monteserin MC; Benito L; Oña F; Lastra AM
    Br J Haematol; 1997 Nov; 99(2):464-5. PubMed ID: 9375774
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia.
    Owen C; Christofides A; Johnson N; Lawrence T; MacDonald D; Ward C
    Leuk Lymphoma; 2017 Dec; 58(12):2777-2785. PubMed ID: 28509580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease in chronic lymphocytic leukaemia.
    García Vela JA; García Marco JA
    Med Clin (Barc); 2018 Feb; 150(4):144-149. PubMed ID: 28864095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry.
    Aw A; Kim HT; Fernandes SM; Hoang K; Kasar S; Faham M; Brown JR
    Leuk Lymphoma; 2018 Aug; 59(8):1986-1989. PubMed ID: 29164966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.